D. Papadatos-Pastos - Concepedia

Author

D. Papadatos-Pastos

Also Known As

D Papadatos-Pastos, D. Papadatos-Pastos, Dionysios Papadatos-Pastos

Publications

458

Citations

H-Index

Concepts

All Affiliations

D. Papadatos-Pastos is an author at University Hospital of Heraklion specializing in cancer therapeutics, tumor biology, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	145
2	Health Sciences	2	2	72
3	Pathology	2	2	106
4	Pharmacology	2	2	72
5	Immunology	1	1	73

D. Papadatos-Pastos

Publications

282

Citations

H-Index

Page 1

	Year	Citations
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome Zacharenia Saridaki, D. Papadatos-Pastos, Maria Tzardi, British Journal of Cancer	2010	118
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer N. Xenidis, V. Markos, Stella Apostolaki, Annals of Oncology Breast OncologyMedicineImmunologyClinical RelevancePathology	2007	73
A phase I study evaluating GDC-0941, an oral phosphoinositide-3 kinase (PI3K) inhibitor, in patients with advanced solid tumors or multiple myeloma. Víctor Moreno, Richard D. Baird, Kinjal Shah, Journal of Clinical Oncology Gdc-0941 Plasma ConcentrationsAdvanced Solid TumorsTumor BiologyMagnetic Resonance ImagingHematological Malignancy	2011	39
Phase I trial of a first-in-class ATR inhibitor VX-970 as monotherapy (mono) or in combination (combo) with carboplatin (CP) incorporating pharmacodynamics (PD) studies. Brent O’Carrigan, Maria J. de Miguel, D. Papadatos-Pastos, Journal of Clinical Oncology PathologyPharmacotherapyTumor BiologyMetronomic TherapyClinical Trials	2016	33
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem Dimitrios C. Ziogas, D. Papadatos-Pastos, Kiruthikah Thillai, European Journal of Gastroenterology & Hepatology	2016	19

Page 1